Literature DB >> 1716107

Epitope mapping.

A C Horsfall1, F C Hay, A J Soltys, M G Jones.   

Abstract

The immune response to extrinsic and intrinsic antigens involves specific antigen receptors on T and B cells. The precise antigenic determinants, or epitopes, recognized by these receptors are discrete sequences within the native antigen. The ability to identify and manufacture key epitopes in the immune response has important implications for disease diagnosis and immunointervention. Consequently, increasingly sophisticated technologies are being applied to epitope mapping. This report from a recent workshop gives a balanced view of progress to date and the challenges ahead.

Mesh:

Substances:

Year:  1991        PMID: 1716107     DOI: 10.1016/0167-5699(91)90029-S

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  13 in total

Review 1.  B-cell epitopes of scleroderma-specific autoantigens.

Authors:  R Verheijen
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 2.  Autoantibodies against small cytoplasmic ribonucleoproteins: the anti-Ro/SS-A and anti-La/SS-B autoimmune response. A review of autoantibody detection, autoantigen composition, autoantibody-disease associations and possible etiologic mechanisms.

Authors:  J F Meilof
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

3.  Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins.

Authors:  Wei-Guo Hu; Jun Wei; Heng-Chuan Xia; Xin-Xiu Yang; Feng Li; Guang-Di Li; Yuan Wang; Zu-Chuan Zhang
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

4.  Catalytic domain of PDC-E2 contains epitopes recognized by antimitochondrial antibodies in primary biliary cirrhosis.

Authors:  Sandra Braun; Christoph Berg; Sandra Buck; Michael Gregor; Reinhild Klein
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

5.  Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.

Authors:  S H Pincus; K G Messer; D H Schwartz; G K Lewis; B S Graham; W A Blattner; G Fisher
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Antibodies to the protein core of the small cell lung cancer workshop antigen cluster-w4 and to the leucocyte workshop antigen CD24 recognize the same short protein sequence leucine-alanine-proline.

Authors:  E Weber; H P Lehmann; A G Beck-Sickinger; E J Wawrzynczak; R Waibel; G Folkers; R A Stahel
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

7.  Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope.

Authors:  S Lombardi; C Garzelli; C La Rosa; L Zaccaro; S Specter; G Malvaldi; F Tozzini; F Esposito; M Bendinelli
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues.

Authors:  L Crawford-Miksza; D P Schnurr
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  Localization of a T-cell epitope of superantigen toxic shock syndrome toxin 1 to residues 125 to 158.

Authors:  W G Hu; X H Zhu; Y Z Wu; Z C Jia
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

10.  A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitope.

Authors:  S W Ludmerer; D Benincasa; G E Mark; N D Christensen
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.